Table 2.
Comparison of variables between the total study population, NVO and IVO.
| Variables | Total (n = 145) | NVO (n = 114) | IVO (n = 31) | p |
|---|---|---|---|---|
| TBantibody, n (%) | 0.462 | |||
| negative | 133 (92) | 103 (90) | 30 (97) | |
| positive | 12 (8) | 11 (10) | 1 (3) | |
| IGRAs, n (%) | 0.018 | |||
| negative | 88 (61) | 63 (55) | 25 (81) | |
| positive | 57 (39) | 51 (45) | 6 (19) | |
| WBC, 10^9/L | 6.3 (4.9, 8.53) | 6.2 (4.82, 8.03) | 6.61 (5.15, 11.2) | 0.204 |
| RBC, 10^12/L | 3.91 ± 0.67 | 3.94 ± 0.69 | 3.78 ± 0.55 | 0.174 |
| HGB, g/L | 113.72 ± 20.62 | 115.18 ± 21.05 | 108.35 ± 18.27 | 0.08 |
| PLT, 10^9/L | 268 ± 93.11 | 257.46 ± 86.65 | 306.77 ± 106.57 | 0.022 |
| Neut, 10^9/L | 4.02 (2.95, 6.2) | 3.98 (2.9, 5.8) | 4.1 (3.3, 8.59) | 0.135 |
| lymph, 10^9/L | 1.4 (1, 1.84) | 1.38 (0.98, 1.87) | 1.4 (1.19, 1.81) | 0.53 |
| EO, 10^9/L | 0.1 (0.06, 0.2) | 0.1 (0.06, 0.18) | 0.1 (0.04, 0.23) | 0.79 |
| BASO, 10^9/L | 0.02 (0, 0.04) | 0.02 (0, 0.04) | 0.01 (0, 0.03) | 0.17 |
| Mono, 10^9/L | 0.5 (0.4, 0.7) | 0.5 (0.4, 0.7) | 0.5 (0.4, 0.62) | 0.382 |
| Neut%, % | 66.54 ± 11.66 | 65.69 ± 11.55 | 69.69 ± 11.7 | 0.097 |
| Lymph%, % | 21 (15.3, 28.7) | 21.45 (16.05, 29.08) | 19.4 (14.9, 26.3) | 0.346 |
| BASO%, % | 0.5 (0.3, 0.7) | 0.5 (0.32, 0.7) | 0.3 (0.15, 0.55) | 0.017 |
| Eo%, % | 1.7 (0.7, 3.1) | 1.75 (0.8, 3.1) | 1.5 (0.35, 3.15) | 0.434 |
| Mono%, % | 8 (6.2, 9.8) | 8.1 (6.6, 10.07) | 6.7 (4.95, 8.75) | 0.005 |
| RDW, % | 13.5 (12.7, 14.5) | 13.4 (12.7, 14.4) | 14.1 (12.75, 14.8) | 0.233 |
| PCT, 10^9/L | 0.22 (0.18, 0.27) | 0.22 (0.18, 0.26) | 0.23 (0.18, 0.31) | 0.071 |
| MPV, fL | 9.6 (8.3, 15.7) | 9.6 (8.31, 15.67) | 14.6 (8.3, 15.8) | 0.875 |
| TP, g/L | 68.6 (64.9, 72.6) | 68.3 (64.53, 72.47) | 69.8 (65.9, 75.05) | 0.205 |
| A, g/L | 36.95 ± 4.9 | 37.01 ± 4.78 | 36.74 ± 5.4 | 0.8 |
| G, g/L | 31.2 (27.9, 36.2) | 30.55 (27.52, 35.4) | 33.4 (30, 37.2) | 0.033 |
| AG | 1.2 (1, 1.35) | 1.2 (1, 1.38) | 1.1 (0.9, 1.25) | 0.065 |
| ALT, U/L | 19 (12.4, 31.4) | 18.9 (12.62, 28.8) | 24.1 (11.35, 38.8) | 0.551 |
| AST, U/L | 20.4 (16.7, 28.6) | 20.5 (16.8, 27.5) | 19.8 (15.85, 33.75) | 0.875 |
| BUN, mmol/L | 5.36 (4.07, 6.92) | 5.36 (4.11, 6.65) | 5.07 (3.6, 7.44) | 0.78 |
| Cr, umol/L | 68.9 (55.9, 81) | 68.95 (55.08, 81.38) | 68.1 (58.15, 77.55) | 0.931 |
| TG, mmol/L | 1.24 (0.92, 1.62) | 1.22 (0.92, 1.6) | 1.34 (1.02, 1.76) | 0.276 |
| Chol, mmol/L | 4.37 ± 1.17 | 4.39 ± 1.18 | 4.31 ± 1.16 | 0.751 |
| HDL, mmol/L | 1.09 ± 0.3 | 1.08 ± 0.3 | 1.1 ± 0.31 | 0.816 |
| LDL, mmol/L | 2.88 (2.48, 3.45) | 2.93 (2.48, 3.46) | 2.66 (2.49, 3.36) | 0.442 |
| BS, mmol/L | 5.34 (4.85, 6.21) | 5.24 (4.84, 6.08) | 5.47 (5.08, 6.81) | 0.279 |
| PT, s | 12.37 ± 1.16 | 12.29 ± 1.14 | 12.68 ± 1.19 | 0.103 |
| APTT, s | 31.4 (28.2, 36.8) | 30.45 (27.63, 35.8) | 34.4 (30.9, 40.65) | 0.008 |
| INR | 1 (0.93, 1.06) | 0.98 (0.93, 1.05) | 1.03 (0.94, 1.06) | 0.263 |
| D_dimer, mg/L | 0.39 (0.21, 0.81) | 0.36 (0.19, 0.7) | 0.68 (0.37, 1.1) | 0.01 |
| ESR, mm/h | 84 (46, 111) | 80.5 (43.25, 109) | 86 (60.5, 120) | 0.339 |
| CRP, mg/L | 25.6 (9.44, 53.38) | 23.43 (9.5, 49.85) | 30.99 (9.03, 73.85) | 0.17 |
| Procalcitonin, n (%) | 0.305 | |||
| negative | 119 (82) | 96 (84) | 23 (74) | |
| positive | 26 (18) | 18 (16) | 8 (26) |
Notes: Values are presented as the mean ± standard deviation for continuous variables or median (interquartile range) for nonnormally distributed variables. Categorical variables are presented as numbers (percentages). The p values indicate the level of statistical significance for the differences observed.